文献速递免疫规划

连续接种流感疫苗是否会降低保护效果:一项系统综述与Meta分析

Does consecutive influenza vaccination reduce protection against influenza: A systematic review and meta-analysis.
PubMed 文献 · Vaccine · 2018-05-01

该系统综述与Meta分析评估连续接种流感疫苗是否较当季接种降低疫苗有效性(VE)。5项随机对照试验(11,987名参与者)未显示VE显著降低(连续两季VE 71%,95%CI 62-78% vs 当季VE 58%,95%CI 48-66%;OR 0.88,95%CI 0.62-1.26,p=0.49,I²=39%);28项观察性研究(28,627名参与者)同样未显示降低(连续两季VE 41%,95%CI 30-51% vs 当季VE 47%,95%CI 39-54%;OR 1.14,95%CI 0.98-1.32,p=0.09,I²=63%)。作者结论为现有证据不支持连续接种降低VE,但因证据确定性极低,不能排除有效性降低的可能。

要点

  • 5项随机对照试验未显示连续两季接种较当季接种显著降低VE(OR 0.88,95%CI 0.62-1.26)。
  • 28项观察性研究同样未显示连续接种降低VE(OR 1.14,95%CI 0.98-1.32)。
  • 证据确定性因无法解释的异质性和不精确性被评定为极低。

核心结论

  • 现有证据不支持连续接种流感疫苗会降低疫苗有效性,但因证据确定性极低,不能排除有效性降低的可能。

研究设计与样本

  • 系统综述与Meta分析,纳入报告2个或以上连续流感季节实验室确诊流感感染的随机对照试验和观察性研究。
  • 纳入5项随机对照试验共11,987名参与者和28项观察性研究共28,627名参与者。
  • 检索MEDLINE、EMBASE和Cochrane对照试验中心注册库(CENTRAL),检索时间自建库至2017年4月26日,并检索纳入研究的参考文献。

主要发现

  • 5项随机对照试验中,连续两季接种者VE为71%(95%CI 62-78%),当季接种者VE为58%(95%CI 48-66%),OR 0.88(95%CI 0.62-1.26,p=0.49,I²=39%)。
  • 28项观察性研究中,连续两季接种者VE为41%(95%CI 30-51%),当季接种者VE为47%(95%CI 39-54%),OR 1.14(95%CI 0.98-1.32,p=0.09,I²=63%)。
  • 按流感型/亚型、疫苗类型、年龄、疫苗匹配和合并症进行的亚组分析支持上述结果,但剂量反应结果不一致。
  • 因无法解释的异质性和不精确性,证据确定性被评定为极低。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 纳入样本量相对较小且事件率较低的研究导致汇总VE和OR估计不精确。
  • 汇总VE和OR估计基于未校正数据。
  • 证据确定性因无法解释的异质性和不精确性被评定为极低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Vaccination against influenza on an annual basis is widely recommended, yet recent studies suggest consecutive vaccination may reduce vaccine effectiveness (VE). PURPOSE: To assess whether when examining the entirety of existing data consecutive influenza vaccination reduces VE compared to current season influenza vaccination. DATA SOURCES: MEDLINE, EMBASE and the Cochrane Central Register of Controlled Trials (CENTRAL) from inception to April 26, 2017; citations of included studies. STUDY SELECTION: Randomized, controlled trials (RCTs) and observational studies of children, adults and/or the elderly that reported laboratory-confirmed influenza infection over 2 or more consecutive influenza seasons were eligible. DATA EXTRACTION: Data related to study characteristics, participant demographics, cases of influenza infection by vaccination group and risk of bias assessment was extracted in duplicate. DATA SYNTHESIS: Five RCTs involving 11,987 participants did not show a significant reduction in VE when participants vaccinated in two consecutive seasons (VE 71%, 95% CI 62-78%) were compared to those vaccinated in the current season (VE 58%, 95% CI 48-66%) (odds ratio [OR] 0.88, 95% CI 0.62-1.26, p = 0.49, I2 = 39%). Twenty-eight observational studies involving 28,627 participants also did not show a reduction (VE for two consecutive seasons 41%, 95% CI 30-51% compared to VE for current season 47%, 95% CI 39-54%; OR 1.14, 95% CI 0.98-1.32, p = 0.09, I2 = 63%). Results from subgroup analyses by influenza type/subtype, vaccine type, age, vaccine match and co-morbidity support these findings; however, dose-response results were inconsistent. Certainty in the evidence was assessed to be very low due to unexplained heterogeneity and imprecision. LIMITATIONS: The inclusion of studies with relatively small sample sizes and low event rates contributed to the imprecision of summary VE and OR estimates, which were based on unadjusted data. CONCLUSION: Available evidence does not support a reduction in VE with consecutive influenza vaccination, but the possibility of reduced effectiveness cannot be ruled out due to very low certainty in this evidence. FUNDING SOURCE: CIHR Foundation Grant (PROSPERO: CRD42017059893).

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Bartoszko JJ, McNamara IF, Aras OAZ, et al. Does consecutive influenza vaccination reduce protection against influenza: A systematic review and meta-analysis. Vaccine. 2018. PMID: 29724509. doi:10.1016/j.vaccine.2018.04.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。